Chronic myeloid leukemia (CML) is a myeloid proliferative disorder driven by constitutive activation of tyrosine kinase due to abnormal chromosome translocation with the formation of BCR-ABL (breakpoint cluster region-Abelson) fusion gene. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.